Clinical and genetic registries in psoriatic disease

Journal of Rheumatology

Volumn 35, Issue 7, 2008, Pages 1458-1463

  Gladman, Dafna D ^a,n   Rahman, Proton ^b   Krueger, Gerald G ^c   Mease, Philip J ^d   Qureshi, Abrar A ^e   Dutz, Jan P ^f   Lindqvist, Ulla ^g   Carneiro, Sueli ^h   Helliwell, Philip S ⁱ   Ujfalussy, Ilona ^j   Gottlieb, Alice B ^k   Behrens, Frank ^a,l   Ståhle, Mona ^m  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Seattle Rhumatology Associates   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UPPSALA UNIVERSITY   (Sweden)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

^j Policlinic of the Hospitaller Brothers of St John of God ^*  (Hungary)

^k TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l GOETHE UNIVERSITY   (Germany)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ TORONTO WESTERN HOSPITAL   (Canada)

more..

Author keywords

Clinical registries; Genetic studies; Psoriasis; Psoriatic arthritis

Indexed keywords

HLA B ANTIGEN; HLA B27 ANTIGEN; HLA DQ ANTIGEN; HLA DR7 ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 4 RECEPTOR;

ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFERENCE PAPER; CROHN DISEASE; ERYTHROCYTE SEDIMENTATION RATE; FUNDING; GENE OVEREXPRESSION; GENETIC MARKER; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; MEDICAL ETHICS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REGISTER; SINGLE NUCLEOTIDE POLYMORPHISM;

CLINICAL TRIALS AS TOPIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PSORIASIS; REGISTRIES;

EID: 47349133568     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Gladman DD, Menter A. Introduction/overview on clinical registries. Ann Rheum Dis 2005;64 Suppl 2:ii101-2.
2. Gladman DD, Farewell VT. Longitudinal cohort studies. J Rheumatol 2005;32 Suppl 72:30-2.
3. Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56:2708-14.
4. Kremer JM. The CORRONA database. Autoimmun Rev 2006;5:46-54.
5. Reddy SM, Schwartzman JS, Abramson SB, Chang H, Kremer JM, Greenberg JD. Comparison of disease activity and functional status among psoriatic arthritis subtypes [abstract]. Arthritis Rheum 2006;54 Suppl:S712.
6. Reddy SM, Reed G, Anandarajah A, et al. Comparative analysis of disease activity, radiographic features, and bone density in psoriatic and rheumatoid arthritis [abstract]. Arthritis Rheum 2005;53 Suppl:S640.
7. Kremer JM, Reed G. Obesity is an independent contributor to functional capacity and inflammation in rheumatoid arthritis and psoriatic arthritis [abstract]. Ann Rheum Dis 2006;65 Suppl 1:307.
8. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273-90.
9. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3.
10. Rahman P. IL-23 variants predisposing to Crohn's disease are also associated with psoriatic arthritis [abstract]. Ann Rheum Dis 2007;66 Suppl 11:98.
11. Zheng Y, Danilenko DM, Valdez P, et al. Interleukin-22, a T(H) 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51.
12. Kruse S, Japha T, Tedner M. et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999;96:365-71.
13. Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet 2003;72:1505-14.
14. Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE 2007;2:e841.
15. Ehrlich A, Koch T, Amin B, et al. Development and reliability testing of a standardized questionnaire to assess psoriasis phenotype. J Am Acad Dermatol 2006;54:987 e1-14.
16. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005;141:1527-34.
17. Christensen TE, Callis KP, Papenfuss J, et al. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J Invest Dermatol 2006;126:2397-403.
18. Rakkhit T, Panko JM, Christensen TE, et al. Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response. Br J Dermatol 2008 (in press).